Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Reported Earlier, Theratechnologies Enters Definitive Agreement To Be Acquired By CB Biotechnology For $3.01 Per Share Plus Contingent Value Right

Author: Benzinga Newsdesk | July 03, 2025 02:16am

Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per share
Upfront and total potential cash consideration represent respectively a 126% and 216% premium to Nasdaq closing price on date prior to announcement of Future Pak's initial non-binding proposal
Transaction with Future Pak represents culmination of sale process whereby Theratechnologies solicited interest from a number of potential counterparties
Board unanimously recommends that shareholders approve the transaction

Posted In: THTX